- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Human Lung Cancer Organoid Growth Medium Plus |
| Catalog No. | RESK-0700 |
| Description | Human Lung Cancer Organoid Growth Medium Plus is a serum-free complete medium designed for the establishment and long-term culture of lung cancer organoids derived from human cells or tissues. In the presence of a basement membrane matrix, the medium's specific components and abundant cytokines promote the rapid growth of lung cancer cells and their efficient formation into lung cancer organoids. The organoid formation process is smooth and rapid while maintaining high lung cancer cell identity and viability, supporting downstream studies of physiological function, disease research, and precision medicine. This Plus version is an upgraded formulation of the standard Human Lung Cancer Organoid Growth Medium. The buffer system and nutrient composition have been optimized, improving the medium's resistance to external environmental stress and its overall stability. |
| Intended Use | For the establishment and long-term culture of human lung cancer organoids from cell- or tissue-derived samples. Applications include tumor disease modeling, drug efficacy evaluation, and compound toxicity assessment. |
| Principle / Technology | Organoid culture technology. When cells or tissue fragments are embedded in a basement membrane matrix, the medium's specific components and abundant cytokines drive lung cancer cells to rapidly grow and self-organize into three-dimensional lung cancer organoids while retaining tumor heterogeneity. |
| Sample Type | Cells, tissues |
| Performance Range / Specifications | Broad applicability: suitable for tumor disease modeling, drug efficacy evaluation, and toxicity assessment. Efficient and stable culture performance while retaining tumor heterogeneity. Plus version with optimized buffer system and nutrient composition for improved resistance to environmental stress and enhanced stability. |
| Reaction Conditions / Protocol | Embed isolated human lung cancer cells or tissue fragments in a basement membrane matrix, then overlay with this medium for organoid establishment and long-term culture. |
| Components / Formulation | Serum-free complete medium comprising Part I and Part II components, containing specific proprietary components and abundant cytokines optimized for human lung cancer organoid growth; upgraded Plus formulation with an optimized buffer system and nutrient composition. |
| Storage Conditions | Part I: store at 2 °C to 8 °C, protected from light. Part II: store at -25 °C to -15 °C. |
| Shelf Life | 12 months (Part I at 2 °C to 8 °C, protected from light; Part II at -25 °C to -15 °C). |
| Package Specifications | 100 mL, 500 mL |
| Product Form | Liquid |
| Shipping Conditions | Part I: shipped with ice packs. Part II: shipped on dry ice. |
| Expiration Date / Stability | Stable for 12 months when stored as recommended (Part I at 2 °C to 8 °C protected from light; Part II at -25 °C to -15 °C). |
| Regulatory / Compliance | For research use only. |
| Compatibility | Used together with a basement membrane matrix for three-dimensional organoid culture. |
| Recommended Buffer System | Optimized buffer system in the Plus formulation, providing improved resistance to external environmental stress and enhanced medium stability. |
| Application Notes / Precautions | Applicable to lung cancer organoids derived from human cells or tissues. Supports tumor disease modeling, drug efficacy evaluation, and compound toxicity assessment. Store Part I at 2 °C to 8 °C protected from light and Part II at -25 °C to -15 °C. |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagnoTech. All rights reserved.
